PrC-210

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePrC-210
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree radicals scavengers
TargetsFree radicals
Therapy Area/IndicationsRadiation sickness
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProcertus Biopharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProcertus Biopharm Inc
Active IndicationsN/A
Inactive IndicationsRadiation sickness

Other Information

ATC CodeN/A
Related LinksN/A